The journey from basic chemical compounds to life-saving medications is a complex and highly specialized process. Central to this transformation are chemical intermediates, molecules that serve as crucial building blocks in multi-step synthesis pathways. Among these, (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide, identified by CAS number 219835-31-1, holds a significant position, particularly in the pharmaceutical industry.

This compound is primarily recognized for its indispensable role as an intermediate in the synthesis of Lacosamide. Lacosamide is a tertiary amino acid derivative that functions as an anticonvulsant medication. It is widely prescribed for the treatment of partial-onset seizures in adults and children, making its reliable production a matter of significant public health importance. The specific stereochemistry of (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide is critical, as it directly dictates the stereochemistry of the final Lacosamide molecule, influencing its pharmacological activity and safety profile.

As a pharmaceutical intermediate manufacturer, our focus is on producing this compound with exceptional purity and the correct chiral configuration. The synthesis process must be meticulously controlled to ensure that the final product meets stringent quality standards, typically characterized by:

  • Appearance: A consistent White to off-white powder form.
  • Specific Rotation: Precise values confirming the desired enantiomer (e.g., +4.4º to +5.1º).
  • Melting Point: A sharp melting point within the expected range (147-152°C) indicates high purity.
  • Low Impurity Levels: This includes minimal loss on drying (≤1.0%), low residue on ignition (≤0.1%), and controlled levels of heavy metals (≤20ppm).

The demand for high-quality (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide directly correlates with the global need for Lacosamide. Pharmaceutical companies seeking to buy this intermediate often look for reliable suppliers who can guarantee both quality and scalability. When you purchase (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide, you are investing in the foundational quality of your pharmaceutical product.

Furthermore, the development of new therapeutic agents may also identify novel applications for such chiral building blocks. While its primary role is currently in Lacosamide production, the unique structural features of (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide could lend themselves to other complex organic syntheses in the future. Researchers and formulators interested in exploring these possibilities can engage with manufacturers to discuss custom synthesis needs or inquire about its availability for R&D purposes.

In essence, (R)-N-Benzyl-2-(benzyloxycarbonylamino)-3-hydroxypropionamide is more than just a chemical compound; it is a critical enabler of modern medicine. Its reliable and high-purity production by dedicated manufacturers is fundamental to ensuring patients have access to essential treatments like Lacosamide.